DealsJun 16, 2026, 06:06 AM
Vivos Therapeutics Partners with SPCVA to Form AIM Florida, LLC
AI Summary
Vivos Therapeutics, Inc. has entered into a Collaboration Agreement with South Palm Cardiovascular Associates, LLC (SPCVA) to form AIM Florida, LLC. This new entity will function as a management services organization providing administrative and non-clinical support to clinical entities focused on sleep apnea diagnosis and treatment. Vivos expects to hold at least 80% of AIM Florida's membership interests, with SPCVA holding up to 20%. The collaboration initially targets the Palm Beach County, Florida market and is seen as a scalable model for future expansion nationwide.
Key Highlights
- Vivos Therapeutics and South Palm Cardiovascular Associates to form AIM Florida, LLC.
- AIM Florida will provide administrative and non-clinical support services to clinical entities.
- Vivos expects to hold at least 80% membership interest in AIM Florida; SPCVA up to 20%.
- Collaboration initially focused on sleep apnea diagnosis and treatment in Palm Beach County, Florida.
- AIM Florida model expected to contribute to Vivos' cash flow and profitability.
- Potential for scalable model expansion to other Florida communities and cardiology groups nationwide.
Price Impact
More from VVOS